Capital allowances and investment timing
Why good projects stall and how to unlock them
UK manufacturers are operating in a difficult investment climate. Labour is constrained, energy costs remain volatile, and margin pressure is persistent. At the same time, many businesses know that automation, capacity upgrades and energy efficiency investment are not optional if they want to remain competitive.
And yet, a surprising number of sensible capital projects stall or are quietly deferred.
This is rarely because the technology does not work, or because management lacks ambition. More often, it is because investment decisions are framed through the wrong lens.
The problem is not capital allowances. It is how they are used.
The UK currently offers one of the most generous capital allowance regimes it has had in decades for incorporated businesses investing in plant and machinery. Full expensing, a permanent £1 million Annual Investment Allowance, and enhanced relief on certain assets materially improve the post-tax economics of investment.
Despite this, capital allowances are still commonly treated as a year-end tax adjustment. Something the accountants “sort out later”.
When allowances sit outside the investment decision itself, their value is diluted. Projects are assessed on headline cost, short-term accounting impact, or EBITDA optics, rather than on post-tax cash return and funding reality.
The result is not bad compliance. It is suboptimal decision-making.
The quiet distortion created by EBITDA
EBITDA is a useful metric. It allows comparability across businesses and strips out financing and accounting differences. It is widely understood by boards, banks and investors.
It is also incomplete.
EBITDA deliberately excludes depreciation and tax, which means it excludes the very channels through which capital allowances deliver value. Accelerated relief can materially improve cash flow without improving EBITDA at all.
When investment decisions are driven primarily by EBITDA impact, several distortions creep in:
Capital expenditure is judged on its short-term EBITDA drag rather than its long-term cash contribution
Projects with strong post-tax payback are delayed because they “hurt EBITDA” in the first year
Management teams optimise for covenant optics rather than economic value
The timing advantage of allowances is invisible in board papers
This is particularly acute in manufacturing, where capital intensity is high and the gap between accounting performance and cash reality can be wide.
The issue is not that EBITDA is wrong. It is that it is often used on its own.
Capital allowances as a timing and sequencing issue
The real value of capital allowances lies in timing.
Two projects with identical headline costs and identical long-term returns can have very different short-term cash profiles depending on when relief is obtained, how it is claimed, and how it aligns with funding.
When allowances are built into investment appraisal at the outset, several things change:
Capex appraisals reflect post-tax cash cost, not just gross spend
Payback periods shorten once relief timing is modelled
Funding requirements become clearer, reducing surprises and last-minute pressure
Projects can be sequenced intelligently to protect liquidity and covenant headroom
This does not require aggressive tax planning. It requires integration.
The question shifts from “Can we afford this?” to “How do we invest at the right pace, in the right order, with cash impact understood?”
Why this matters more now
In a lower interest rate environment, poor sequencing could sometimes be absorbed. Today, it cannot.
Banks and investors are increasingly focused on evidence-based cash flow forecasting, not just adjusted profit metrics. They want to see how investment affects liquidity, headroom and resilience, not just headline returns.
At the same time, manufacturers are being pushed towards capital-heavy solutions to structural problems such as labour availability and energy efficiency. These are precisely the types of investments where allowances and relief timing matter most.
Ignoring that dimension does not make decisions safer. It makes them blunter.
Decision quality versus compliance
There is an important distinction between claiming allowances correctly and using them well.
Most businesses will eventually claim the relief they are entitled to. That is a compliance outcome.
Far fewer use allowances as a decision tool. That is a strategic outcome.
The difference lies in whether tax, finance and operations are considered together at the point of decision, rather than sequentially after the fact.
This is where the role of a fractional CFO is often misunderstood. The value is not in replacing tax advisers or preparing claims. It is in helping boards and management teams make better investment decisions with the full economic picture in view.
A better framing for investment decisions
The most effective investment discussions tend to move beyond a single metric and instead ask:
What is the post-tax cash cost of this investment?
How does relief timing affect funding and liquidity?
What sequencing protects optionality if conditions change?
How will this look to lenders and investors, not just accountants?
When those questions are answered clearly, decisions become easier.
Projects that once looked marginal often become viable. Others are deferred deliberately, not accidentally. Conversations with banks and investors become grounded in evidence rather than reassurance.
Conclusion
Capital allowances do not create value on their own. They accelerate and improve the cash outcomes of good decisions.
When investment is framed purely through EBITDA or headline spend, that benefit is obscured. When allowances are integrated into financial planning and investment appraisal, they become a practical tool for making better choices, at the right time, and at the right pace.
For manufacturers navigating a capital-intensive future, that difference matters.
Decisions create value. Allowances simply help reveal it.